Scroll down


Would you like to explore the possibilities for obtaining a license for this technology? You can contact our licensing team by mail. Would you like to know more about our technologies and licensing possibilities? Visit our webpage about Licensing KeyGene’s proprietary technologies.


The inventors developed a genomic selection method based on genome-wide complementarity, taking into account recombination probabilities. Via the computation of a Genomic Estimated Breeding Values (GEBVs) for combinations of individuals of a breeding population, KeyGene® Directed Genomic Selection allows to efficiently select optimal combinations of breeding parents resulting in the best performing offspring for one or more traits of interest.


As cost-effective genotyping techniques are emerging, genomic selection becomes an interesting alternative for breeders to marker-assisted selection and/or phenotype selection. Genomic selection is especially beneficial for highly complex traits or combinations of traits. The prediction-based strategy of the present invention making use of genotype/phenotype models allows for selecting without actual phenotyping.


In order to save costly breeding time, selecting the optional combinations of breeding parents is crucial. KeyGene® Directed Genomic Selection allows to bring about the best performing offspring in a minimal number of breeding cycles.


Click on the link below for an overview of the patent family in the European Patent Register:


Please note that the European Patent Register may not be extensive and/or accurate, for which KeyGene is not responsible. Please contact your patent expert for further information.